Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roxane Laboratories has announced the approval of its abbreviated new drug application for Zaleplon capsules CIV, 5mg and 10mg, a sedative/hypnotic, mainly used for insomnia.
Subscribe to our email newsletter
The product is available in bottles of 100 capsules for immediate shipment to wholesalers and pharmacies across the US.
Roxane Laboratories’s Zaleplon capsules CIV are AB rated to Sonata (zaleplon). Annual sales of Sonata capsules CIV are approximately $87.8 million, the company said.